Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.

Cordycepin blocks lung injury-associated inflammation and promotes BRCA1-deficient breast cancer cell killing by effectively inhibiting PARP.

Model: LPS-induced acute lung injury

Cordycepin blocked LPS-induced airway neutrophilia and inflammatory gene expression in mice, acting as a PARP inhibitor.

Extraction: extract · Supplied extraction confidence: 0.8. Machine-extracted fields require source verification.